<DOC>
	<DOCNO>NCT00646828</DOCNO>
	<brief_summary>Vascular cardiac alteration associate aldosterone effect evidence experimental model aldosterone receptor blockade clear benefit cardiac disease ( heart failure ) . The study aim assess vascular cardiac alteration adult chronic increase circulate aldosterone without hypertension . The investigated population patient rare disease , pseudohypoaldosteronism type 1 , due heterozygous inactivate mutation mineralocorticoid receptor .</brief_summary>
	<brief_title>Cardiovascular Evaluation Adult PHA 1 Patients</brief_title>
	<detailed_description>The study include adult patient mineralocorticoid receptor mutation compare affected relative . It include also relatives adult relative patient PHA1 mutation find . Cardiovascular evaluation conduct cardiac vascular ultrasound assessment cardiac NMR , ambulatory blood pressure measurement . Protocol duration 2 day . Detailed genetic study conduct family without identify mutation MINERALORECEPTOR .</detailed_description>
	<mesh_term>Pseudohypoaldosteronism</mesh_term>
	<mesh_term>Mineralocorticoids</mesh_term>
	<criteria>Inclusion criterion : Age 18 Male female gender Genotype PHA1.NET network Exclusion criterion : Not membership regime Social Security CMU Against indication realization MRI Cardiac NMR possible Known cardiovascular disease person carry MR mutation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Pseudohypoaldosteronism type 1</keyword>
	<keyword>Mineralocorticoid receptor</keyword>
	<keyword>Aldosterone</keyword>
	<keyword>Cardiovascular disease</keyword>
</DOC>